In recent years, the PDE4 family has been the subject of extensive research due to its significance as a major therapeutic target for intervention in various inflammatory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and rheumatoid arthritis (RA). The gene discussed is PDE4A; the disease is chronic obstructive pulmonary disease.